论文部分内容阅读
目的:观察浅表性膀胱癌合并前列腺增生患者采取TURBT(经尿道膀胱癌电切术)+TURP(经尿道前列腺电切术)的治疗效果及安全性。方法:选取自2012年8月至2014年8月我院30例浅表性膀胱癌会合并前列腺增生例患者作为本次观察对象。其中观察组15例为TURBT+TURP术治疗患者,另外15例患者为分期行TURBT、TURP术。分别对两组患者治疗后的排尿状况及安全性进行分析。结果:手术结束后,观察组治疗效果显著优于对照组,安全性较高(P<0.05),具有统计学意义。结论:对浅表性膀胱癌合并前列腺增生患者实施TURBT+TURP术可有效提升整体治疗质量,减少相关术后不良反应发生,值得临床推广应用。
Objective: To observe the efficacy and safety of TURBT (transurethral resection of bladder cancer) + TURP (transurethral resection of prostate) in patients with superficial bladder cancer complicated with benign prostatic hyperplasia. Methods: From August 2012 to August 2014 30 cases of superficial bladder cancer in our hospital will be combined with benign prostatic hyperplasia patients as the observation object. The observation group of 15 patients treated by TURBT + TURP patients, and the other 15 patients were staged TURBT, TURP surgery. The urination and safety of the two groups after treatment were analyzed respectively. Results: After the operation, the observation group was significantly better than the control group, with higher safety (P <0.05), which was statistically significant. Conclusion: TURBT + TURP can effectively improve the overall quality of treatment for patients with superficial bladder cancer complicated with benign prostatic hyperplasia and reduce the incidence of postoperative adverse reactions. It is worthy of clinical application.